HistoSonics Edison® Histotripsy System Treats First Pancreatic Tumor Patients in GANNON Trial

MINNEAPOLIS, United States:   HistoSonics, the developer and manufacturer of the Edison® Histotripsy System, announced today the first patients with pancreatic

READ MORE

Pimicotinib Significantly Improved Outcomes for Patients with Tenosynovial Giant Cell Tumor in a Global Phase III Trial

Darmstadt, Germany:   Phase III MANEUVER study met primary endpoint, with an objective response rate at week 25 of 54.0%

READ MORE